Ignite Creation Date:
2025-12-25 @ 1:46 AM
Ignite Modification Date:
2025-12-26 @ 3:44 AM
Study NCT ID:
NCT00354094
Status:
TERMINATED
Last Update Posted:
2007-11-08
First Post:
2006-07-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
[S,S]-Reboxetine Long Term Safety Study In Post-Shingles Pain.
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D010146', 'term': 'Pain'}], 'ancestors': [{'id': 'D009461', 'term': 'Neurologic Manifestations'}, {'id': 'D012816', 'term': 'Signs and Symptoms'}, {'id': 'D013568', 'term': 'Pathological Conditions, Signs and Symptoms'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'C524178', 'term': 'O-methyl reboxetine'}]}}, 'protocolSection': {'designModule': {'phases': ['PHASE2'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'NONE'}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'count': 600}}, 'statusModule': {'whyStopped': 'The study was stopped due to business/operational issues.', 'overallStatus': 'TERMINATED', 'startDateStruct': {'date': '2006-11'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2007-11', 'completionDateStruct': {'date': '2007-10', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2007-11-07', 'studyFirstSubmitDate': '2006-07-18', 'studyFirstSubmitQcDate': '2006-07-18', 'lastUpdatePostDateStruct': {'date': '2007-11-08', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2006-07-20', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Vital signs'}, {'measure': 'Physical examination'}, {'measure': '12-lead ECG'}, {'measure': 'Hematology/Biochemistry'}, {'measure': 'Adverse events'}], 'secondaryOutcomes': [{'measure': 'Pain Visual Analogue Scale'}, {'measure': 'Patient Global Impression of Change'}, {'measure': 'Neuropathic Pain Symptom Inventory'}, {'measure': 'Modified Brief Pain Inventory - Short Form'}, {'measure': 'SF-12 Health Survey'}, {'measure': 'EQ-5D'}, {'measure': 'Analgesic Treatment Satisfaction Scale'}, {'measure': 'Pain-related Medication Utilization'}]}, 'conditionsModule': {'conditions': ['Pain']}, 'referencesModule': {'seeAlsoLinks': [{'url': 'https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A6061030&StudyName=%5BS%2CS%5D-Reboxetine%20Long%20Term%20Safety%20Study%20In%20Post-Shingles%20Pain.', 'label': 'To obtain contact information for a study center near you, click here.'}]}, 'descriptionModule': {'briefSummary': 'The purpose of this study is to assess the long term (up to 2 years) safety and tolerability of \\[S,S\\]-Reboxetine in patients with pain after shingles.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Patients must have pain present for more than 3 months after healing of the shingles skin rash.\n* Patients at screening must have a score of \\>/=40mm on the pain visual analogue scale.\n\nExclusion Criteria:\n\n* Patients with significant hepatic impairment.\n* Patients with other severe pain, that may impair the self-assessment of pain due to postherpetic neuralgia (pain after shingles).'}, 'identificationModule': {'nctId': 'NCT00354094', 'briefTitle': '[S,S]-Reboxetine Long Term Safety Study In Post-Shingles Pain.', 'organization': {'class': 'INDUSTRY', 'fullName': 'Pfizer'}, 'officialTitle': 'A Phase 2B Long-Term, Randomized, Open-Label, Safety And Tolerability Trial Comparing [S,S]-Reboxetine (PNU-165442g) With Routine Care In Patients With Postherpetic Neuralgia (PHN).', 'orgStudyIdInfo': {'id': 'A6061030'}}, 'armsInterventionsModule': {'interventions': [{'name': '[S,S]-Reboxetine', 'type': 'DRUG'}]}, 'contactsLocationsModule': {'locations': [{'zip': '33606', 'city': 'Tampa', 'state': 'Florida', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 27.94752, 'lon': -82.45843}}, {'zip': '33407', 'city': 'West Palm Beach', 'state': 'Florida', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 26.71534, 'lon': -80.05337}}, {'zip': '27401', 'city': 'Greensboro', 'state': 'North Carolina', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 36.07264, 'lon': -79.79198}}, {'zip': '58104', 'city': 'Fargo', 'state': 'North Dakota', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 46.87719, 'lon': -96.7898}}, {'zip': '02864', 'city': 'Cumberland', 'state': 'Rhode Island', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 41.96677, 'lon': -71.43284}}, {'zip': '78213', 'city': 'San Antonio', 'state': 'Texas', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 29.42412, 'lon': -98.49363}}, {'zip': 'C1280AEB', 'city': 'Buenos Aires', 'state': 'Buenos Aires', 'country': 'Argentina', 'facility': 'Pfizer Investigational Site'}, {'zip': 'C1015ABR', 'city': 'Buenos Aires', 'country': 'Argentina', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': -34.61315, 'lon': -58.37723}}, {'zip': 'C1133AAW', 'city': 'Buenos Aires', 'country': 'Argentina', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': -34.61315, 'lon': -58.37723}}, {'zip': 'C1428AQK', 'city': 'Buenos Aires', 'country': 'Argentina', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': -34.61315, 'lon': -58.37723}}, {'zip': 'P3A 1Y4', 'city': 'Greater Sudbury', 'state': 'Ontario', 'country': 'Canada', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 46.49, 'lon': -80.99001}}, {'zip': 'P3A 1Y8', 'city': 'Greater Sudbury', 'state': 'Ontario', 'country': 'Canada', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 46.49, 'lon': -80.99001}}, {'zip': 'P3E 1H5', 'city': 'Greater Sudbury', 'state': 'Ontario', 'country': 'Canada', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 46.49, 'lon': -80.99001}}, {'zip': 'M3M 3E5', 'city': 'Toronto', 'state': 'Ontario', 'country': 'Canada', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 43.70643, 'lon': -79.39864}}, {'zip': 'H3S 2W1', 'city': 'Montreal', 'state': 'Quebec', 'country': 'Canada', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 45.50884, 'lon': -73.58781}}, {'zip': '2520021', 'city': 'Viña del Mar', 'state': 'Región de Valparaíso', 'country': 'Chile', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': -33.02457, 'lon': -71.55183}}, {'city': 'Santiago', 'state': 'RM', 'country': 'Chile', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': -33.45694, 'lon': -70.64827}}, {'zip': '21000', 'city': 'Split', 'country': 'Croatia', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 43.50891, 'lon': 16.43915}}, {'zip': '500 033', 'city': 'Hyderabad', 'state': 'Andhra Pradhesh', 'country': 'India', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 17.38405, 'lon': 78.45636}}, {'zip': '160 012', 'city': 'Chandigarh', 'state': 'Punjab', 'country': 'India', 'facility': 'Pfizer Investigational Site'}, {'zip': '560 034', 'city': 'Bangalore', 'country': 'India', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 12.97194, 'lon': 77.59369}}, {'zip': '600 116', 'city': 'Chennai', 'country': 'India', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 13.08784, 'lon': 80.27847}}, {'zip': '500 033', 'city': 'Hyderabad', 'country': 'India', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 17.38405, 'lon': 78.45636}}, {'zip': '110 002', 'city': 'New Delhi', 'country': 'India', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 28.62137, 'lon': 77.2148}}, {'zip': '110 076', 'city': 'New Delhi', 'country': 'India', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 28.62137, 'lon': 77.2148}}, {'zip': '50009', 'city': 'Kaunas', 'country': 'Lithuania', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 54.90156, 'lon': 23.90909}}, {'zip': '92304', 'city': 'Klaipėda', 'country': 'Lithuania', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 55.7068, 'lon': 21.13912}}, {'zip': '35144', 'city': 'Panevezys', 'country': 'Lithuania', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 55.73186, 'lon': 24.35983}}, {'zip': '76231', 'city': 'Šiauliai', 'country': 'Lithuania', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 55.93333, 'lon': 23.31667}}, {'zip': '97000', 'city': 'Mérida', 'state': 'Yucatán', 'country': 'Mexico', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 20.967, 'lon': -89.62318}}, {'zip': '81-855', 'city': 'Sopot', 'country': 'Poland', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 54.4418, 'lon': 18.56003}}, {'zip': '32005', 'city': 'Ourense', 'state': 'OURENSE', 'country': 'Spain', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 42.33669, 'lon': -7.86407}}, {'zip': 'S-141 86', 'city': 'Stockholm', 'country': 'Sweden', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 59.32938, 'lon': 18.06871}}, {'zip': 'TN40 1JJ', 'city': 'Bexhill-on-Sea', 'state': 'East Sussex', 'country': 'United Kingdom', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 50.85023, 'lon': 0.47095}}, {'zip': 'KT15 2BH', 'city': 'Addlestone', 'state': 'SURREY', 'country': 'United Kingdom', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 51.37135, 'lon': -0.49353}}, {'zip': 'B49 5DZ', 'city': 'Alcester', 'country': 'United Kingdom', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 52.21667, 'lon': -1.86667}}, {'zip': 'TN40 3RJ', 'city': 'East Sussex', 'country': 'United Kingdom', 'facility': 'Pfizer Investigational Site'}, {'zip': 'EC1A 7BE', 'city': 'London', 'country': 'United Kingdom', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 51.50853, 'lon': -0.12574}}, {'zip': 'SW18 4DD', 'city': 'London', 'country': 'United Kingdom', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 51.50853, 'lon': -0.12574}}, {'zip': 'WC1X 8LD', 'city': 'London', 'country': 'United Kingdom', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 51.50853, 'lon': -0.12574}}], 'overallOfficials': [{'name': 'Pfizer CT.gov Call Center', 'role': 'STUDY_DIRECTOR', 'affiliation': 'Pfizer'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Pfizer', 'class': 'INDUSTRY'}}}}